Skip to content

King Pharmaceuticals KG Reserve for insurance claims

Reserve for insurance claims at other companies

Arch Capital Group logo
Arch Capital GroupACGL
$34.11B+10.2%
Everest Group logo
Everest GroupEG
$34.65B+10.0%
SiriusPoint logo
SiriusPointSPNT
$5.73B-0.5%
Skyward Specialty Insurance Group, Inc. logo
Skyward Specialty Insurance Group, Inc.SKWD
$2.92B+56.0%
Selective Insurance Group logo
Selective Insurance GroupSIGI
$7.42B+12.2%
Reinsurance Group of America logo
Reinsurance Group of AmericaRGA

Segments

By product

See full
Total$416.57M
Other reconciling items excluded from loss development tables$148.48M
European Hospital Liability$88.89M
General Liability$82.07M
International$28.77M
Commercial Auto Liability$20.29M

By segment

See full
AmTrust Reinsurance$554.51M

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's reserve for insurance claims.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's reserve for insurance claims?
King Pharmaceuticals (KG) reported reserve for insurance claims of $314.15M in Q1 2026.
What does reserve for insurance claims mean?
This represents the estimated liability for insurance claims that have been reported but not yet paid, as well as claims that have been incurred but not yet reported. It is a fundamental actuarial estimate of future obligations and directly impacts the company's profitability and solvency. Investors scrutinize this to evaluate the adequacy of the company's reserving practices and historical loss experience.